메뉴 건너뛰기




Volumn 1, Issue 1, 2004, Pages 73-81

New insights into mechanisms of immune-mediated glomerular diseases

Author keywords

[No Author keywords available]

Indexed keywords

ABETIMUS; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; B 69588; BELIMUMAB; CALCINEURIN INHIBITOR; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECULIZUMAB; ETANERCEPT; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 6 ANTIBODY; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; PIRFENIDONE; RAPAMYCIN; RITUXIMAB; ROSCOVITINE; UNCLASSIFIED DRUG;

EID: 23744450836     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.07.002     Document Type: Review
Times cited : (2)

References (27)
  • 1
    • 0033135569 scopus 로고    scopus 로고
    • Glomerulonephritis
    • Couser, W.G. (1999) Glomerulonephritis. Lancet 353, 1509-1515
    • (1999) Lancet , vol.353 , pp. 1509-1515
    • Couser, W.G.1
  • 2
    • 33645187800 scopus 로고    scopus 로고
    • Introduction to glomerular disease: Pathogenesis and classification
    • (Johnson, R.J. and Feehally, J., eds), Mosby
    • Johnson, R.J. et al. (2003) Introduction to glomerular disease: pathogenesis and classification. In: Comprehensive Clinical Nephrology (Johnson, R.J. and Feehally, J., eds), pp. 243-253, Mosby
    • (2003) Comprehensive Clinical Nephrology , pp. 243-253
    • Johnson, R.J.1
  • 3
    • 0032957969 scopus 로고    scopus 로고
    • Natural history and treatment of lupus nephritis
    • Austin, H.A. and Balow, J.E. (1999) Natural history and treatment of lupus nephritis. Semin. Nephrol. 19, 2-11
    • (1999) Semin. Nephrol. , vol.19 , pp. 2-11
    • Austin, H.A.1    Balow, J.E.2
  • 4
    • 0344492212 scopus 로고    scopus 로고
    • Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
    • Baechler, E.C. et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. PNAS 1000, 2610-2615
    • (2003) PNAS , vol.1000 , pp. 2610-2615
    • Baechler, E.C.1
  • 5
    • 0348226819 scopus 로고    scopus 로고
    • Recent advances in the pathogenesis of lupus nephritis: Autoantibodies and B cells
    • Su, W. and Madaio, M.P. (2003) Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells. Semin. Nephrol. 23, 564-568
    • (2003) Semin. Nephrol. , vol.23 , pp. 564-568
    • Su, W.1    Madaio, M.P.2
  • 6
    • 2542505506 scopus 로고    scopus 로고
    • The role of complement in the development of systemic lupus erythematosus
    • Manderson, A.P. et al. (2004) The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22, 431-456
    • (2004) Annu. Rev. Immunol. , vol.22 , pp. 431-456
    • Manderson, A.P.1
  • 7
    • 0033538468 scopus 로고    scopus 로고
    • BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator
    • Moore, P.A. et al. (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263
    • (1999) Science , vol.285 , pp. 260-263
    • Moore, P.A.1
  • 8
    • 0037247281 scopus 로고    scopus 로고
    • Newer drugs for the treatment of lupus nephritis
    • Kuiper-Geertsma, D.G. and Derksen, R.H. (2003) Newer drugs for the treatment of lupus nephritis. Drugs 63, 167-180
    • (2003) Drugs , vol.63 , pp. 167-180
    • Kuiper-Geertsma, D.G.1    Derksen, R.H.2
  • 9
    • 0034128373 scopus 로고    scopus 로고
    • ANCA glomerulonephritis and vasculitis: A Chapel Hill perspective
    • Falk, R.J. et al. (2000) ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin. Nephrol. 20, 233-243
    • (2000) Semin. Nephrol. , vol.20 , pp. 233-243
    • Falk, R.J.1
  • 10
    • 0042570785 scopus 로고    scopus 로고
    • Neutrophil-activating potential of antineutrophil cytoplasmic autoantibodies
    • Rarok, A.A. et al. (2003) Neutrophil-activating potential of antineutrophil cytoplasmic autoantibodies. JLB 74, 3-15
    • (2003) JLB , vol.74 , pp. 3-15
    • Rarok, A.A.1
  • 11
    • 0036790387 scopus 로고    scopus 로고
    • Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
    • Xiao, H. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. JCI 110, 955-963
    • (2002) JCI , vol.110 , pp. 955-963
    • Xiao, H.1
  • 12
    • 1842508029 scopus 로고    scopus 로고
    • Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3
    • Pendergraft, W.F. et al. (2004) Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 10, 72-79
    • (2004) Nat Med. , vol.10 , pp. 72-79
    • Pendergraft, W.F.1
  • 13
    • 0035995335 scopus 로고    scopus 로고
    • Glomerular Remodeling: Novel therapeutic approaches derived from the apparently chaotic growth factor network
    • Floege, J. (2002) Glomerular Remodeling: novel therapeutic approaches derived from the apparently chaotic growth factor network. Nephron 91, 582-587
    • (2002) Nephron , vol.91 , pp. 582-587
    • Floege, J.1
  • 14
    • 0037217177 scopus 로고    scopus 로고
    • Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease
    • Kurogi, Y. (2003) Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med. Res. Rev. 23, 15-31
    • (2003) Med. Res. Rev. , vol.23 , pp. 15-31
    • Kurogi, Y.1
  • 15
    • 0042388115 scopus 로고    scopus 로고
    • A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis
    • Huang, Y. et al. (2003) A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. JCI 112, 379-388
    • (2003) JCI , vol.112 , pp. 379-388
    • Huang, Y.1
  • 16
    • 0038717407 scopus 로고    scopus 로고
    • BMP-7 counteracts TGF-β-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
    • Zeisberg, M. et al. (2003) BMP-7 counteracts TGF-β-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964-968
    • (2003) Nat. Med. , vol.9 , pp. 964-968
    • Zeisberg, M.1
  • 17
    • 0742288423 scopus 로고    scopus 로고
    • Make or break for costimulatory Blockers. News feature
    • Garber, K. (2004) Make or break for costimulatory Blockers. News feature. Nat. Biotechnol. 22, 145-147
    • (2004) Nat. Biotechnol. , vol.22 , pp. 145-147
    • Garber, K.1
  • 18
    • 0030781307 scopus 로고    scopus 로고
    • Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist
    • Pippin, J.W. et al. (1997) Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist. JCI 100, 2512-2520
    • (1997) JCI , vol.100 , pp. 2512-2520
    • Pippin, J.W.1
  • 19
    • 0242524381 scopus 로고    scopus 로고
    • Pentoxifylline in the treatment of refractory nephrotic syndrome secondary to lupus nephritis
    • Galindo-Rodriguez, G. et al. (2003) Pentoxifylline in the treatment of refractory nephrotic syndrome secondary to lupus nephritis. J. Rheumatol. 30, 2382-2384
    • (2003) J. Rheumatol. , vol.30 , pp. 2382-2384
    • Galindo-Rodriguez, G.1
  • 20
    • 0037638841 scopus 로고    scopus 로고
    • Rituximab therapy and autoimmune disorders
    • Silverman, G.J. and Weisman, S. (2003) Rituximab therapy and autoimmune disorders. Arthritis Rheum. 48, 1484-1492
    • (2003) Arthritis Rheum. , vol.48 , pp. 1484-1492
    • Silverman, G.J.1    Weisman, S.2
  • 21
    • 0037315004 scopus 로고    scopus 로고
    • Complement inhibition in renal disease
    • Inal, J.M. et al. (2003) Complement inhibition in renal disease. Nephrol. Dial. Transplant. 18, 237-240
    • (2003) Nephrol. Dial. Transplant. , vol.18 , pp. 237-240
    • Inal, J.M.1
  • 22
    • 0028084439 scopus 로고
    • Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis
    • Tang, W.W. et al. (1994) Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. JCI 93, 273-279
    • (1994) JCI , vol.93 , pp. 273-279
    • Tang, W.W.1
  • 23
    • 0033883903 scopus 로고    scopus 로고
    • Clinical and biologic effects of anti-interleukin-10 monocloncal antibody administration in systemic lupus erythematosus
    • Llorente, L. et al. (2000) Clinical and biologic effects of anti-interleukin-10 monocloncal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43, 1790-1800
    • (2000) Arthritis Rheum. , vol.43 , pp. 1790-1800
    • Llorente, L.1
  • 24
    • 0033136794 scopus 로고    scopus 로고
    • Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury
    • Allen, A.R. et al. (1999) Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J. Immunol. 162, 5519-5527
    • (1999) J. Immunol. , vol.162 , pp. 5519-5527
    • Allen, A.R.1
  • 25
    • 0025277164 scopus 로고
    • Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1
    • Border, W. A. et al. (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346, 371-374
    • (1990) Nature , vol.346 , pp. 371-374
    • Border, W.A.1
  • 26
    • 0038188724 scopus 로고    scopus 로고
    • Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F(1) mice
    • Kinoshita, K. et al. (2003) Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F(1) mice. J. Immunol. 170, 5793-5798
    • (2003) J. Immunol. , vol.170 , pp. 5793-5798
    • Kinoshita, K.1
  • 27
    • 0031940491 scopus 로고    scopus 로고
    • Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease
    • Zoja, C. et al. (1998) Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. KI 53, 726-734
    • (1998) KI , vol.53 , pp. 726-734
    • Zoja, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.